Generic Dexone depresses formation, release, and activity of endogenous mediators of inflammation, including prostaglandins, kinins, histamine, liposomal enzymes, and complement expression. Also modifies the body's immune response. More info »
Celtic Pharma Announces Successful Completion of Phase I/II study of Xerecept ... - MarketWatch (press release)
Celtic Pharma Announces Successful Completion of Phase I/II study of Xerecept .
Suspected illegal supply of Western medicine by Chinese medicine practitioner - 7thSpace Interactive (press release)
Suspected illegal supply of Western medicine by Chinese medicine practitioner7thSpace Interactive (press release)'The Government Laboratory's analysis results today detected the presence of dexamethasone and ketoconazole in a sample of the yellowish cream provided by the complainant, both of which could attain therapeutic levels if used in accordance with the .
Celgene announces three phase III Revlimid trials in newly diagnosed MM patients - pharmabiz.com
Celgene announces three phase III Revlimid trials in newly diagnosed MM patientspharmabiz.
Over 90 Percent of Surveyed Hematologist-Oncologists in the U.S. are Aware ... - MarketWatch (press release)
Over 90 Percent of Surveyed Hematologist-Oncologists in the U.
New Multiple Myeloma Treatments On The Horizon (ASCO 2012) - The Myeloma Beacon
New Multiple Myeloma Treatments On The Horizon (ASCO 2012)The Myeloma BeaconSiltuximab is a compound that blocks the activity of IL-6, a protein that facilitates myeloma cell growth and resistance to dexamethasone (Decadron).